搜尋結果
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 18 小時前AstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a ...
Shares of this gene editing company are due to surge more than 45%, Citi says
CNBC· 10 小時前After a period of steady underperformance, investors should pick up shares of biotech Prime ...
Health Care Roundup: Market Talk
The Wall Street Journal· 12 小時前Find insights on Ionis Pharmaceuticals, Roche, WuXi, and more in the latest Market Talks covering the Health Care sector.